Ratings Mutares SE & Co. KGaA

Equities

MUX

DE000A2NB650

Market Closed - Xetra 11:41:50 2024-04-29 EDT 5-day change 1st Jan Change
42.35 EUR +2.42% Intraday chart for Mutares SE & Co. KGaA +4.83% +19.63%

Strengths

  • Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
  • The stock, which is currently worth 2024 to 0.15 times its sales, is clearly overvalued in comparison with peers.
  • The company has a low valuation given the cash flows generated by its activity.
  • The company is one of the best yield companies with high dividend expectations.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.

Weaknesses

  • The company's earnings growth outlook lacks momentum and is a weakness.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • With an expected P/E ratio at 23.9 and 344.58 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Investment Management & Fund Operators

1st Jan change Capi. Investor Rating ESG Refinitiv
+19.63% 930M
C
-7.87% 88.47B
C-
+15.00% 84.55B
C+
+13.44% 26.01B
B-
-5.42% 17.28B -
B+
+13.81% 16.57B
C+
+6.41% 14.28B
B
-21.52% 13.16B
C+
+17.66% 9.52B
B
+27.79% 8.75B
C-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. MUX Stock
  4. Ratings Mutares SE & Co. KGaA